Compare Affectis Pharmaceuticals vs Mast Therapeutics
Customers evaluate the quality of Affectis Pharmaceuticals's products using the following success metrics.
Overview
Affectis Pharmaceuticals is 22 yrs old and is based in Germany.
Affectis Pharmaceuticals, fka neuronova, is a biopharmaceutical company developing drugs for the treatment of psychiatric and inflammatory disorders.
Mast Therapeutics is 29 yrs old and is based in United States.
Mast Therapeutics (NYSEMKT: MSTX), fka ADVENTRX Pharmaceuticals, is a biopharmaceutical company focused on in-licensing, developing, and commercializing proprietary product candidates primarily for the treatment of cancer. Mast's lead product candidate, AIR001, is a sodium nitrite solution for intermittent inhalation via nebulization in Phase 2 clinical development for the treatment of HFpEF.
Demo Video
Leadership
Michael Hamacher (Chief Executive Officer)
Carrie McQueen (Chief Financial Officer)
Funding
Investors
EQT Life Sciences, Bayern Kapital
Savara, Centrum Bank AG
Product
Benefits
Products
Customers
Known Partners
Why They Buy
Information not available because Affectis Pharmaceuticals has not claimed their profile.
Work for Affectis Pharmaceuticals? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Affectis Pharmaceuticals?
Claim your profile now.
Information not available because Mast Therapeutics has not claimed their profile.
Work for Mast Therapeutics? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Mast Therapeutics?
Claim your profile now.